Revalia Bio, Inc

USest. 2022revaliabio.com

Manufacturing — sector from SBTi (Pharmaceuticals, Biotechnology and Life Sciences)

Revalia Bio is a company that uses AI to transform donated human organs and tissues into high-fidelity biological data for drug and device development. The company was founded by Yale scientists and has developed the Human Data Stack platform to generate, integrate, and deliver human-biology insight at scale.

This listing was imported from public sources and has not been claimed by the organisation. Claim this listing

Claims and their evidence

  • Science Based Targets initiativeVerified: Verified by ESGOS assisted review — registry dataset: sciencebasedtargets.org companies-excel (retrieved 2026-08-11) against SBTi corporate target validation on 2026-08-11 · Expires 2027-08-15

Related organisations

Compare Revalia Bio, Inc with:Rexford Industrial Realty, Inc.Reynolds Consumer Products Inc.Rice Fruit CompanyRich Products CorporationRivianRoadRunner Recycling

Embed this record

The badge is served live from ESGOS: it always shows this profile's current state, and degrades automatically if a verification lapses.

ESGOS record badge for Revalia Bio, Inc

<a href="https://esgos.org/en/o/revalia-bio-inc"><img src="https://esgos.org/badge/revalia-bio-inc.svg" alt="ESGOS record — Revalia Bio, Inc" height="48"></a>

Watch this organisation

One email a week when something changes — a verification lands, lapses, or approaches expiry. No account needed.